Type(s) of Cancer
Neuroendocrine
Neuroendocrine
Study Phase
Phase 3
Study Completion Date
January 2015
January 2015
NCT00569127Uploaded 02-24-2018
Access via NCI by Request
PDS UID: nci-data-371
Phase III Prospective Randomized Comparison of Depot Octreotide Plus Interferon Alpha Versus Depot Octreotide Plus Bevacizumab (NSC #704865) in Advanced, Poor Prognosis Carcinoid Patients
Files: NCT00569127-D2



Data DictionaryNCT00569127-D2-Data-Dictionary.pdf

DATANCT00569127-D2-Dataset.csv

OTHERREADME.pdf
Files: NCT00569127-D1



Data DictionaryNCT00569127-D1-Data-Dictionary.pdf

DATANCT00569127-D1-Dataset.csv

OTHERREADME.pdf